Source: Virtual Congress 2021 – Sarcopenia in chronic respiratory disease: new definitions, assessment and treatment options



Rating:

Share or cite this content

Citations should be made in the following way:
N. Greening (Leicester (Leicestershire), United Kingdom). Underlying mechanisms and pharmacological approaches for treatment of sarcopenia. Virtual Congress 2021 – Sarcopenia in chronic respiratory disease: new definitions, assessment and treatment options

Member's Comments

No comment yet.

Related content which might interest you: COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 Genes, mechanisms and new therapies for asthma Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Lung hypertension: developmental mechanisms and assesment therapeutic action efficiency Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Treatment of COPD: from pharmacological to instrumental therapies Source: Eur Respir Rev 2009; 19: 7-23 Year: 2010 Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy Source: Eur Respir J, 59 (2) 2102245; 10.1183/13993003.02245-2021 Year: 2022 Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies? Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021 Year: 2022 Emerging biologic approaches for the treatment of difficult to control asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 Therapeutic approaches to lung aging Source: International Congress 2016 – The future is now: the challenge of ageing in respiratory medicine Year: 2016 When and how to identify resistance mechanisms to targeted therapies Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019 Year: 2020 Dyspnoea causal mechanisms and treatment options Source: Annual Congress 2011 - Acute breathlessness: the state of the science Year: 2011 The mechanisms of anti-inflammatory action of bronchodilators Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Cellular mechanisms underlying steroid refractory asthma Source: ERS Lung Science Conference 2019 Year: 2019 Genes, intervention and molecular mechanisms in COPD Source: Annual Congress 2007 - Physiological year in review Year: 2007 The consequences of novel insights into the pathophysiology of asthma for its treatment Source: Annual Congress 2008 - Should asthma no longer be considered an allergic disease? Year: 2008 To the molecular genetic mechanisms of the COPD pathogenesis Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Pharmacological and Non-pharmacological therapies that modulare lung function decline Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today Year: 2021